Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of K-285 vs Oral Indomethacin in Healthy Volunteers
NCT03712241Phase 1Completed
- Start
- Oct 2018
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of indomethacin and l-Menthol in delayed onset muscle soreness (DOMS) (4 arms). Primary endpoints: Maximum Plasma Concentration and Area under the plasma versus concentration time curve. Started Oct 2018; status: completed.
02
Drugs
indomethacinl-Menthol
03
Conditions
delayed onset muscle soreness (DOMS)
Beyond the preview
Go deeper on NCT03712241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03712241.